Applied Therapeutics, Inc. Profile Avatar - Palmy Investing

Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatmen…

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Applied Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Applied Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Applied Therapeutics, Inc..

End of APLT's Analysis
CIK: 1697532 CUSIP: 03828A101 ISIN: US03828A1016 LEI: - UEI: -
Secondary Listings
APLT has no secondary listings inside our databases.